NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球冠狀動脈支架市場:2020∼2026年

Global Coronary Stent Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 1008067
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球冠狀動脈支架市場:2020∼2026年 Global Coronary Stent Market 2020-2026
出版日期: 2021年04月19日內容資訊: 英文
簡介

全球冠狀動脈支架的市場規模,預計以約6.9%的年複合成長率擴大為在預測期間內。冠狀動脈支架,是用鈷合金和不鏽鋼等金屬製作的網膜狀小彈性管,用作支持體。帶動全球冠狀動脈支架市場成長的主要原因,有全球醫療費增加,糖尿病人口的擴大和酒精消費增加,高血壓增加,高齡化等。但,價格壓力,產品核可的法規問題,支架的植入相關的併發症,產品的缺點,冠狀動脈疾病的替代治療方法的利用可能性,抑制市場成長。

本報告提供全球冠狀動脈支架市場相關調查,市場概要,以及各傳送模式,各類型,各地區的趨勢,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 規則

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 主要的策略分析

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 全球冠狀動脈支架市場,各傳送模式
    • 球囊擴張型支架
    • 自動擴張型支架
  • 全球冠狀動脈支架市場,各類型
    • 傳統金屬支架
    • 藥劑溶出性血管支架
    • 生物可吸收支架

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 其他地區

第7章 企業簡介

  • Andramed GmbH
  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • Biosensors International Group, Ltd.
  • Becton, Dickinson, and Co.
  • BIOTRONIK SE & Co. KG
  • Endocor GmbH
  • Fortimedix B.V.
  • Hexacath
  • Inspire Md Inc.
  • Kyoto Medical Planning
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corp.
  • Medtronic PLC
  • OrbusNeich Medical Co., Ltd.
  • Terumo Corp.
  • Translumina GmbH
  • Vascular Concepts Ltd.
目錄
Product Code: OMR2023360

Global Coronary Stent Market Size, Share & Trends Analysis Report by Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bioabsorbable Stents), Forecast Period 2021-2027

The global coronary stent market is anticipated to grow at a CAGR of around 6.9% during the forecast period. A coronary stent is a mesh-like small elastic tube made up of metal such as cobalt alloy or stainless steel that acts as support. Stents are attached to small balloons and opened inside the artery to support the vessel wall and reinstate blood flow. Stenting is relatively more comfortable for patients in comparison to coronary artery bypass heart surgery as it does not involve any major incision.

Some of the key factors driving the growth of the global coronary stent market include the rise in the global health care expenditure, growing diabetic population coupled with the increased consumption of alcohol, increase in hypertension, and ageing population. However, pricing pressure, regulatory issues for product approval and complications associated with implantation of stents, product failure and availability of alternative treatment options for coronary artery disease will be restraining the growth of the market.

Segmental Outlook

The global coronary stent market is segmented based on the mode of delivery and type. Based on mode of the delivery, the market is segmented into balloon-expandable stents and self-expanding stents. Based on type, the market is segmented into bare-metal stents, drug-eluting stents, bioabsorbable stents.

Global Coronary Stent Market Share by Type, 2020 (%)

Source: OMR Global

Drug-Eluting Stent is Projected to Contribute a Prominent Share to the Coronary Stent Market

Among type, the drug-eluting stent is projected to contribute a prominent share in the market owing to its better treatment outcomes and its availability at a lower re-obstruction rate. This stent is coated with time-release medicine, where the medication is released into the blood vessel gradually that prevents it from becoming blocked. Drug-eluting stents support preventing plaque buildup relieves chest pain and promotes better flow of blood into the heart. This also reduced the risks of a heart attack. The drug-eluting stent is generally made with a polymer coating that is in form of a metallic, an antirestenotic drug mixed with the polymer.

First-generation drug-eluting stents consist of sirolimus-eluting stents and paclitaxel-eluting stents. The further second generation of drug-eluting stents includes zotarolimus and everolimus-eluting stents. According to American Heart Association, the incremental cost of DES is $1600 currently per stent. The introduction of drug-eluting stents has become the first device that substantially reduces restenosis after stent implantation. The stent delivers high concentrations of either antiproliferative or immunomodulatory compounds for arterial injury and controls the delivery through polymer-based drug release. However, the stent is also associated with certain risks such as kidney damage, bleeding, clotting, abnormal heart rhythm, stroke and others. Despite such risks, the clinical efficacy of DES supports in reducing restenosis undoubtfully.

Regional Outlooks

The global coronary stent market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to have a significant share in the market owing to the increasing patient population with coronary heart diseases, increasing investment in healthcare facilities. There are a large number of coronary stents manufacturers in the US which is resulting in the awareness about the risk factors associated with coronary heart diseases that are resulting in the growth of the market in the region.

Source: OMR Global

Asia-Pacific Will Have Considerable Growth in the Global Coronary Stent Market

Asia-Pacific region is expected to show a lucrative growth rate in the future years. Economic developments and government reforms, especially in countries such as China and India, are supporting the regional growth of the market. Further, a large pool of ageing population with cardiovascular disease, rising PCI procedures, improved reimbursement scenario, and low manufacturing cost of coronary stents in the region are fueling the growth of the market in the region. Other factors such as increased addiction to smoking, and adults influenced by western culture also the factors contributing to the growth of the market.

Market Players Outlook

Some of the key players of the coronary stent market include Abbott Laboratories, Boston Scientific Corp, Biotronik, Medtronic PLC and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers, and acquisitions, collaborations, and new product launch, to stay competitive in the market.

The Report Covers

  • Market value data analysis of 2020 and forecast to 2027.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Penicillin and Streptomycin
  • market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Coronary Stent Market by Mode of Delivery
    • 5.1.1. Balloon-Expandable Stents
    • 5.1.2. Self-Expanding Stents
  • 5.2. Global Coronary Stent Market by Type
    • 5.2.1. Bare-Metal Stents
    • 5.2.2. Drug-Eluting Stents
    • 5.2.3. Bioabsorbable Stents

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Andramed GmbH
  • 7.2. B. Braun Melsungen AG
  • 7.3. Boston Scientific Corp.
  • 7.4. Biosensors International Group, Ltd.
  • 7.5. Becton, Dickinson, and Co.
  • 7.6. BIOTRONIK SE & Co. KG
  • 7.7. Endocor GmbH
  • 7.8. Fortimedix B.V.
  • 7.9. Hexacath
  • 7.10. Inspire Md Inc.
  • 7.11. Kyoto Medical Planning
  • 7.12. Meril Life Sciences Pvt. Ltd.
  • 7.13. Microport Scientific Corp.
  • 7.14. Medtronic PLC
  • 7.15. OrbusNeich Medical Co., Ltd.
  • 7.16. Terumo Corp.
  • 7.17. Translumina GmbH
  • 7.18. Vascular Concepts Ltd.

LIST OF TABLES

  • 1. GLOBAL CORONARY STENT MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2020-2027 ($ MILLION)
  • 2. GLOBAL BALLOON-EXPANDABLE STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL SELF-EXPANDING STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL CORONARY STENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 5. GLOBAL BARE-METAL STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2020-2027 ($ MILLION)
  • 6. GLOBAL DRUG-ELUTING STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. NORTH AMERICAN CORONARY STENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 8. NORTH AMERICAN CORONARY STENT MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2020-2027 ($ MILLION)
  • 9. NORTH AMERICAN CORONARY STENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 10. EUROPEAN CORONARY STENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 11. EUROPEAN CORONARY STENT MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2020-2027 ($ MILLION)
  • 12. EUROPEAN CORONARY STENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 13. ASIA-PACIFIC CORONARY STENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 14. ASIA-PACIFIC CORONARY STENT MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2020-2027 ($ MILLION)
  • 15. ASIA-PACIFIC CORONARY STENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD CORONARY STENT MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2020-2027 ($ MILLION)
  • 17. REST OF THE WORLD CORONARY STENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CORONARY STENT MARKET SHARE BY MODE OF DELIVERY, 2020 VS 2027 (%)
  • 2. GLOBAL CORONARY STENT MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 3. GLOBAL CORONARY STENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. GLOBAL SELF-EXPANDING STENTS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL BARE-METAL STENTS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL DRUG-ELUTING STENTS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL BIOABSORBABLE STENTS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. US CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. CANADA CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. UK CORONARY STENT SIZE, 2020-2027 ($ MILLION)
  • 12. FRANCE CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. GERMANY CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. ITALY CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. SPAIN CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF EUROPE CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. INDIA CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. CHINA CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. JAPAN CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. REST OF ASIA-PACIFIC CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. REST OF THE WORLD CORONARY STENT MARKET SIZE, 2020-2027 ($ MILLION)